<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>biperiden</title><link>http://www.unboundmedicine.com/medline/ebm/research/biperiden</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19694744/full_citation/The_use_of_antipsychotic_and_anticholinergic_antiparkinson_drugs_in_Norway_after_the_withdrawal_of_orphenadrine_</link><description>Gjerden P, Slørdal L, Bramness JG <br/><span class="title">The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine. [Journal Article]</span><br/><span class="source" title="British journal of clinical pharmacology">Br J Clin Pharmacol 2009 Aug; 68(2):238-42.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19694744/abstract/The_use_of_antipsychotic_and_anticholinergic_antiparkinson_drugs_in_Norway_after_the_withdrawal_of_orphenadrine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19694744/full_citation/The_use_of_antipsychotic_and_anticholinergic_antiparkinson_drugs_in_Norway_after_the_withdrawal_of_orphenadrine_">Full Citation</a> | <a href="http://www3.interscience.wiley.com/resolve/openurl%3fgenre=article%26amp;sid=nlm:pubmed%26amp;issn=0306-5251%26amp;date=2009%26amp;volume=68%26amp;issue=2%26amp;spage=238">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19694744/The_use_of_antipsychotic_and_anticholinergic_antiparkinson_drugs_in_Norway_after_the_withdrawal_of_orphenadrine_">Find Related Articles</a> </description></item><item><title>Torticollis under Cyclobenzaprine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19590258/full_citation/Torticollis_under_Cyclobenzaprine_</link><description>Reuss R, Reuter I, Jauss M, et al. <br/><span class="title">Torticollis under Cyclobenzaprine. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pharmacology">Pharmacology 2009 Jul 8; 84(2):91-92.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19590258/abstract/Torticollis_under_Cyclobenzaprine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19590258/full_citation/Torticollis_under_Cyclobenzaprine_">Full Citation</a></description></item><item><title>The antidepressant effects of anticholinergic drugs.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19585799/full_citation/The_antidepressant_effects_of_anticholinergic_drugs_</link><description>Howland RH <br/><span class="title">The antidepressant effects of anticholinergic drugs. [Journal Article]</span><br/><span class="source" title="Journal of psychosocial nursing and mental health services">J Psychosoc Nurs Ment Health Serv 2009 Jun; 47(6):17-20.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19585799/abstract/The_antidepressant_effects_of_anticholinergic_drugs_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19585799/full_citation/The_antidepressant_effects_of_anticholinergic_drugs_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19585799/The_antidepressant_effects_of_anticholinergic_drugs_">Find Related Articles</a> </description></item><item><title>Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19542525/full_citation/Ziprasidone_Vs_Olanzapine_in_Recent_Onset_Schizophrenia_and_Schizoaffective_Disorder:_Results_of_an_8_Week_Double_Blind_Randomized_Controlled_Trial_</link><description>Grootens KP, van Veelen NM, Peuskens J, et al. <br/><span class="title">Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Schizophrenia bulletin">Schizophr Bull 2009 Jun 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19542525/abstract/Ziprasidone_Vs_Olanzapine_in_Recent_Onset_Schizophrenia_and_Schizoaffective_Disorder:_Results_of_an_8_Week_Double_Blind_Randomized_Controlled_Trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19542525/full_citation/Ziprasidone_Vs_Olanzapine_in_Recent_Onset_Schizophrenia_and_Schizoaffective_Disorder:_Results_of_an_8_Week_Double_Blind_Randomized_Controlled_Trial_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19542525/Ziprasidone_Vs_Olanzapine_in_Recent_Onset_Schizophrenia_and_Schizoaffective_Disorder:_Results_of_an_8_Week_Double_Blind_Randomized_Controlled_Trial_">Find Related Articles</a> </description></item><item><title>Effects of Plantago ovata husk on levodopa (with carbidopa) bioavailability in rabbits with autonomic gastrointestinal disorders.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19389862/full_citation/Effects_of_Plantago_ovata_husk_on_levodopa__with_carbidopa__bioavailability_in_rabbits_with_autonomic_gastrointestinal_disorders_</link><description>Garcia JJ, Fernandez N, Calle A, et al. <br/><span class="title">Effects of Plantago ovata husk on levodopa (with carbidopa) bioavailability in rabbits with autonomic gastrointestinal disorders. [JOURNAL ARTICLE]</span><br/><span class="source" title="Drug metabolism and disposition: the biological fate of chemicals">Drug Metab Dispos 2009 Apr 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19389862/abstract/Effects_of_Plantago_ovata_husk_on_levodopa__with_carbidopa__bioavailability_in_rabbits_with_autonomic_gastrointestinal_disorders_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19389862/full_citation/Effects_of_Plantago_ovata_husk_on_levodopa__with_carbidopa__bioavailability_in_rabbits_with_autonomic_gastrointestinal_disorders_">Full Citation</a> | <a href="http://dmd.aspetjournals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19389862">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19389862/Effects_of_Plantago_ovata_husk_on_levodopa__with_carbidopa__bioavailability_in_rabbits_with_autonomic_gastrointestinal_disorders_">Find Related Articles</a> </description></item><item><title>Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19331262/full_citation/Neuroleptic_malignant_syndrome_due_to_risperidone_treatment_in_a_child_with_Joubert_syndrome_</link><description>Vurucu S, Congologlu A, Altun D, et al. <br/><span class="title">Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome. [Journal Article]</span><br/><span class="source" title="Journal of the National Medical Association">J Natl Med Assoc 2009 Mar; 101(3):273-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19331262/abstract/Neuroleptic_malignant_syndrome_due_to_risperidone_treatment_in_a_child_with_Joubert_syndrome_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19331262/full_citation/Neuroleptic_malignant_syndrome_due_to_risperidone_treatment_in_a_child_with_Joubert_syndrome_">Full Citation</a></description></item><item><title>Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19250146/full_citation/Aripiprazole_in_combination_with_other_antipsychotic_drugs_may_worsen_psychosis_</link><description>Adan-Manes J, Garcia-Parajua P <br/><span class="title">Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. [Journal Article]</span><br/><span class="source" title="Journal of clinical pharmacy and therapeutics">J Clin Pharm Ther 2009 Apr; 34(2):245-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19250146/abstract/Aripiprazole_in_combination_with_other_antipsychotic_drugs_may_worsen_psychosis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19250146/full_citation/Aripiprazole_in_combination_with_other_antipsychotic_drugs_may_worsen_psychosis_">Full Citation</a></description></item><item><title>The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19094158/full_citation/The_use_and_potential_abuse_of_anticholinergic_antiparkinson_drugs_in_Norway:_a_pharmacoepidemiological_study_</link><description>Gjerden P, Bramness JG, Slørdal L <br/><span class="title">The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study. [JOURNAL ARTICLE]</span><br/><span class="source" title="British journal of clinical pharmacology">Br J Clin Pharmacol 2008 Dec 16.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19094158/abstract/The_use_and_potential_abuse_of_anticholinergic_antiparkinson_drugs_in_Norway:_a_pharmacoepidemiological_study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19094158/full_citation/The_use_and_potential_abuse_of_anticholinergic_antiparkinson_drugs_in_Norway:_a_pharmacoepidemiological_study_">Full Citation</a> | <a href="http://dx.doi.org/10.1111/j.1365-2125.2008.03342.x">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19094158/The_use_and_potential_abuse_of_anticholinergic_antiparkinson_drugs_in_Norway:_a_pharmacoepidemiological_study_">Find Related Articles</a> </description></item><item><title>Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18851961/full_citation/Biperiden_enhances_L_DOPA_methyl_ester_and_dopamine_D_l__receptor_agonist_SKF_82958_but_antagonizes_D_2_/D_3__receptor_agonist_rotigotine_antihemiparkinsonian_actions_</link><description>Domino EF, Ni L <br/><span class="title">Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="European journal of pharmacology">Eur J Pharmacol 2008 Dec 3; 599(1-3):81-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18851961/abstract/Biperiden_enhances_L_DOPA_methyl_ester_and_dopamine_D_l__receptor_agonist_SKF_82958_but_antagonizes_D_2_/D_3__receptor_agonist_rotigotine_antihemiparkinsonian_actions_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18851961/full_citation/Biperiden_enhances_L_DOPA_methyl_ester_and_dopamine_D_l__receptor_agonist_SKF_82958_but_antagonizes_D_2_/D_3__receptor_agonist_rotigotine_antihemiparkinsonian_actions_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0014-2999(08)00961-8">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18851961/Biperiden_enhances_L_DOPA_methyl_ester_and_dopamine_D_l__receptor_agonist_SKF_82958_but_antagonizes_D_2_/D_3__receptor_agonist_rotigotine_antihemiparkinsonian_actions_">Find Related Articles</a> </description></item><item><title>Striatal D2/D3 Receptor Occupancy, Clinical Response and Side Effects with Amisulpride: An Iodine-123-Iodobenzamide SPET Study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18763218/full_citation/Striatal_D2/D3_Receptor_Occupancy_Clinical_Response_and_Side_Effects_with_Amisulpride:_An_Iodine_123_Iodobenzamide_SPET_Study_</link><description>Meisenzahl EM, Schmitt G, Gründer G, et al. <br/><span class="title">Striatal D2/D3 Receptor Occupancy, Clinical Response and Side Effects with Amisulpride: An Iodine-123-Iodobenzamide SPET Study. [Journal Article]</span><br/><span class="source" title="Pharmacopsychiatry">Pharmacopsychiatry 2008 Sep; 41(5):169-75.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18763218/abstract/Striatal_D2/D3_Receptor_Occupancy_Clinical_Response_and_Side_Effects_with_Amisulpride:_An_Iodine_123_Iodobenzamide_SPET_Study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18763218/full_citation/Striatal_D2/D3_Receptor_Occupancy_Clinical_Response_and_Side_Effects_with_Amisulpride:_An_Iodine_123_Iodobenzamide_SPET_Study_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18763218/Striatal_D2/D3_Receptor_Occupancy_Clinical_Response_and_Side_Effects_with_Amisulpride:_An_Iodine_123_Iodobenzamide_SPET_Study_">Find Related Articles</a> </description></item></channel></rss>